Business
Director salaries and award of share options
Director salaries and award of share options.
About this update from Scancell Holdings Plc
[{"type":"text","content":"\n \n \n RNS Number : 5744L\n Scancell Holdings Plc\n 01 May 2020\n \n \n \n \n 01 May 2020\n \n \n \n \n \n Scancell Holdings plc\n \n \n (\"Scancell\" or the \"Company\")\n \n \n \n \n \n Director reduced salaries and award of share options\n \n \n \n \n \n Scancell (AIM: SCLP), the developer of novel immunotherapies for the treatment of cancer announces that in recognition of the impact of the COVID-19 crisis and to help fund the initial research work to develop a vaccine for COVID-19 the members of the Company's Senior Management Team have agreed to a temporary 25% reduction in salaries with effect from 1st May 2020. None of Scancell's other employees will be affected.\n \n \n \n \n \n Scancell announces that on 30 April 2020 it has granted 1,000,000 share options to acquire ordinary shares of 0.1 pence each in the capital of the Company (\"Ordinary Shares\") to each of the members of its Senior Management Team (Dr John Chiplin, Dr Cliff Holloway, Professor Lindy Durrant, Dr Sally Adams, Dr Richard Goodfellow and Mr Keith Green).\n \n \n \n \n \n The Options have an exercise price of 8.15 pence each and will vest twelve months from the date of Grant.\n \n \n \n \n \n NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM\n \n \n \n \n \n \n \n \n 1\n \n \n \n \n Details of the person discharging managerial responsibilities/person closely associated\n \n \n \n \n \n \n a)\n \n \n \n \n Name\n \n \n \n \n Dr John Chiplin\n \n \n \n \n \n \n 2\n \n \n \n \n Reason for the notification\n \n \n \n \n \n \n a)\n \n \n \n \n Position/status\n \n \n \n \n PDMR\n \n \n \n \n \n \n b)\n \n \n \n \n Initial notification/Amendment\n \n \n \n \n Initial notification\n \n \n \n \n \n \n 3\n \n \n \n \n Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor\n \n \n \n \n \n \n a)\n \n \n \n \n Name\n \n \n \n \n Scancell Holdings plc\n \n \n \n \n \n \n b)\n \n \n \n \n LEI\n \n \n \n \n 2138008RXEG856SNP666 \n \n \n \n \n \n \n 4\n \n \n \n \n Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted\n \n \n \n ...